Reporting Hub https://www.jnj.com/european-medicines-agency-grants-prime-and-advanced-therapy-medicinal-product-designations-to-janssens-rpgr-gene-therapy-for-x-linked-retinitis-pigmentosa https://www.jnj.com/darzalex-faspro-daratumumab-and-hyaluronidase-fihj-becomes-the-first-fda-approved-treatment-for-patients-with-newly-diagnosed-light-chain-al-amyloidosis https://www.jnj.com/media-center/press-releases/janssen-enters-worldwide-collaboration-and-license-agreement-with-chinese-company-legend-biotech-to-develop-investigational-car-t-anti-cancer-therapy https://www.heartline.com/ https://www.prnewswire.com/news-releases/janssen-submits-application-to-us-fda-seeking-approval-of-amivantamab-for-the-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations-301185216.html?tc=eml_cleartime https://www.businesswire.com/news/home/20201228005043/en/Janssen-Submits-European-Marketing-Authorisation-Application-for-Amivantamab-for-the-Treatment-of-Patients-with-Metastatic-Non-Small-Cell-Lung-Cancer-with-EGFR-Exon-20-Insertion-Mutations https://www.businesswire.com/news/home/20201207005110/en/Xencor-Enters-Collaboration-with-Janssen-with-Aim-to-Discover-Novel-CD28-Bispecific-Antibodies-for-the-Treatment-of-Prostate-Cancer https://www.businesswire.com/news/home/20201207005110/en/Xencor-Enters-Collaboration-with-Janssen-with-Aim-to-Discover-Novel-CD28-Bispecific-Antibodies-for-the-Treatment-of-Prostate-Cancer http://ir.macrogenics.com/news-releases/news-release-details/macrogenics-enters-research-collaboration-janssen-develop-novel http://ir.macrogenics.com/news-releases/news-release-details/macrogenics-enters-research-collaboration-janssen-develop-novel https://www.businesswire.com/news/home/20200515005041/en/Lava-Therapeutics-Announces-Collaboration-Janssen-Develop-Bi-specific https://www.monash.edu/pharm/about/news/news-listing/2020/monash-university-to-accelerate-the-development-of-novel-medicine-designed-to-save-womens-lives-in-child-birth-in-collaboration-with-janssen https://www.monash.edu/pharm/about/news/news-listing/2020/monash-university-to-accelerate-the-development-of-novel-medicine-designed-to-save-womens-lives-in-child-birth-in-collaboration-with-janssen Medical Devices innovation: As pioneers in medical devices, Johnson & Johnson Medical Devices Companies (JJMDC) continually focuses on elevating the standard of care, working to expand patient access, improve outcomes, reduce health system costs and drive value.